This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
6 Apr 2011

Merck To Acquire Inspire

Merck says it is buying Inspire Pharmaceuticals for about $430 million to expand its product portfolio with treatments for eye conditions.

New Jersey-based Merck will acquire Inspire Pharmaceuticals for approximately $430 million in cash. The transaction was unanimously approved by the boards of both companies and Inspire’s board recommended that the company's shareholders tender their shares pursuant to the tender offer.

"Merck continues to build upon its long-term commitment to improving therapeutic options for the treatment of eye diseases," said Beverly Lybrand, senior vice president and general manager, neuroscience and ophthalmology, Merck. "This acquisition combines the talented commercialization organization at Inspire with the excellent team already in place at Merck thereby strengthening our ophthalmology business and positioning us for future growth with an expanded portfolio. This deal helps address the needs of patients an

Related News